Search results
Results From The WOW.Com Content Network
The World Health Organization (WHO) provides guidelines for potassium iodide use following a nuclear accident. The dosage of potassium iodide is age-dependent: neonates (<1 month) require 16 mg/day; children aged 1 month to 3 years need 32 mg/day; those aged 3-12 years need 65 mg/day; and individuals over 12 years and adults require 130 mg/day ...
For instance, potassium iodide (KI), administered orally immediately after exposure, may be used to protect the thyroid from ingested radioactive iodine in the event of an accident or attack at a nuclear power plant, or the detonation of a nuclear explosive which would release radioactive iodine.
Potassium iodide (KI) tablets can reduce the risk of cancer in some situations due to slower uptake of ambient radioiodine. Although this does not protect any organ other than the thyroid gland, their effectiveness is still highly dependent on the time of ingestion, which would protect the gland for the duration of a twenty-four-hour period.
Chris Busby of the self styled "European Committee on Radiation Risk", calls the ICRP model "fatally flawed" when it comes to internal exposure. [53] Radiation can cause cancer in most parts of the body, in all animals, and at any age, although radiation-induced solid tumors usually take 10–15 years, and can take up to 40 years, to become ...
Cancer induction is the most significant long-term risk of exposure to a nuclear bomb. Approximately 1 out of every 80 people exposed to 1 Gray will die from cancer, in addition to the normal rate of 20 out of 80. About 1 in 40 people will get cancer, in addition to the typical rates of 16-20 out of 40.
Stochastic effects are those that occur randomly, such as radiation-induced cancer. The consensus of the nuclear industry, nuclear regulators, and governments, is that the incidence of cancers caused by ionizing radiation can be modeled as increasing linearly with effective dose at a rate of 0.055% per rem (5.5%/Sv). [10]
CDE is defined by the United States Nuclear Regulatory Commission in Title 10, Section 20.1003, of the Code of Federal Regulations (10 CFR 20.1003), such that "The Committed dose equivalent, CDE (H T,50) is the dose to some specific organ or tissue of reference (T) that will be received from an intake of radioactive material by an individual during the 50-year period following the intake".
Potassium iodide (KI) is a non radioactive form of iodine that may be taken to reduce the amount of radioactive iodine absorbed by the body's thyroid gland. When taken before or shortly after a radiological exposure, potassium iodide blocks the thyroid glands ability to absorb radioactive iodine.